This valuable work presents how PRDM16 plays a critical role during colloid plexus development, through regulating BMP signaling. Solid evidence supports the context-dependent gene regulatory ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Inc. (Market cap: $34.46M) has reported its financial performance for the fourth quarter of 2023, highlighting a steady cash flow and strategic advancements in its clinical pipeline. According to ...

SAN DIEGO and TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose” or the "Company”) (NASDAQ: APTO, ...

By DANIELLE ROLLON Bahamas Information Services GRAND BAHAMA, The Bahamas — World Cancer Day is observed globally on February ...

Israeli Prime Minister Benjamin Netanyahu is in Washington, D.C., as negotiations between Israel and Hamas are expected to continue amid the first phase of the deal, which was slated to last about ...

Phase two of the three-phase deal is intended to focus on agreements on the release of the remaining hostages and the withdrawal of Israeli troops from Gaza. "Contacts and negotiation on the ...

Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...

The UP Police Constable 2025 Phase 1 PET admit card has been released on the official website, uppbpb.gov.in. Over 1.7 lakh candidates who passed the written test will appear for the exam on ...

BEIJING-China’s initial proposal to tariffs imposed by US President Donald Trump’s administration will centre on restoring the “Phase 1” trade deal signed in 2020 during Mr Trump’s first ...

The return of the 2020 Phase One agreement — which was never implemented due to Trump’s election loss that year to Joe Biden — will be Beijing’s opening gambit in what may be prolonged ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled SAN FRANCISCO and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., ...